described. 6 Rather, the more likely explanation is a minor muscle or soft tissue injury that occurred while she was pulling herself over in bed and resulted in a capillary bleed.
On review of the literature, no previous report of long thoracic nerve palsy and very few reports of brachial plexopathy as a complication of anticoagulation came to our attention. Salam 7 reported a case of a 68-year-old woman receiving warfarin therapy and using crutches who developed total paralysis and a complete loss of sensation in the left arm. That patient underwent evacuation of a large tense hematoma from her left axilla, with satisfactory return of both motor and sensory function. Another report 8 included two cases of brachial plexus compression by a hematoma following jugular puncture. The two patients, one of whom was receiving warfarin therapy, developed partial deficits of upper limb motor and sensory function and were managed successfully with conservative treatment. 8 In a third report, 9 a 68-year-old woman receiving warfarin therapy experienced a fall and had progressive motor loss below the shoulder. A large hematoma compressing the brachial plexus was drained. The patient had progressive return of function over 2 years. 9 Finally, Hoyt et al 2 reported on a 61-year-old man receiving warfarin therapy who fell and developed progressive right extremity weakness culminating in a right wrist drop after 7 days. This patient underwent surgical evacuation of a large hematoma within the coracobrachialis muscle, which was displacing the brachial plexus. Unfortunately, a follow-up examination did not demonstrate significant improvement in his motor or sensory functions.
While the literature contains only a few reports of brachial plexopathy as a complication in patients receiving anticoagulant therapy, there are frequent case reports of brachial plexopathy secondary to a compressive hematoma as a complication of axillary arteriography or arteriotomy. 10 -12 In these cases, the mechanism of plexopathy is thought to be an expanding hematoma within the axillary sheath with secondary compression of the nerves and cords within this sheath. 11 Satisfactory results in affected patients are usually obtained from early surgical intervention, and delaying surgery may result in permanent neurologic damage. 10 -12 Whether a hematoma compressing the brachial plexus should be treated conservatively or surgically depends on anatomic and clinical features. Surgical intervention should be considered for the treatment of hematomas in the axillary sheath and in patients with severe motor or sensory impairment. On the other hand, when the hematoma is small to moderate in size, free to expand into the surrounding soft tissues of the axilla, and the neuropathy is not progressive or severe, conservative treatment is likely warranted with discontinuation or reversal of anticoagulation therapy using vitamin K, protamine sulfate, or fresh frozen plasma to help halt the expansion of the hematoma. LMWH ϭ low-molecular-weight heparin; ML ϭ mediastinal lipomatosis; Xa ϭ activated factor X D eep-seated bleeding complications of treatment with low-molecular-weight heparin (LMWH) usually involve abdominal wall, retroperitoneum, and epidural or spinal spaces, and occur in few treated patients, especially in those with renal failure. 1, 2 Mediastinal lipomatosis (ML) is a complication of high-dose steroid therapy 3 ; it has not been described as a site for spontaneous bleeding in patients receiving anticoagulation therapy. In this report, we describe one patient with systemic lupus erythematosus, antiphospholipid syndrome, and chronic renal insufficiency in whom ML rapidly developed over a few weeks following increasing steroid therapy doses. In our patient, nontraumatic hemomediastinum occurred as a complication of treatment with LMWH. Persistent shock led to surgery for mediastinal decompression and control of bleeding.
Case Report
A 43-year-old black woman was admitted to the medical ICU for a 1-day history of increasing spontaneous chest pain radiating to the left shoulder, dyspnea, and hypotension. Systemic lupus erythematosus, antiphospholipid syndrome, and glomerular extramembranous nephritis had been diagnosed 10 years previously. She had been receiving steroids since 1989, in association with warfarin therapy for both antiphospholipid and nephrotic syndromes. One month before hospital admission, prednisone was increased up to 80 mg/d because of deteriorating renal function. At the same time, a large hematoma of the psoas was diagnosed, and oral antivitamin K was substituted with tinzaparin (14,000 IU/d anti-activated factor X [Xa]).
On hospital admission, her respiratory rate was 30 breaths/min, oxygen saturation was 88% on room air, pulse rate was 120 beats/min, and BP was 80/50 mm Hg at both arms. Physical examination revealed numerous large cutaneous hematomas, swollen neck, exophthalmia, left pleural effusion, and wheezing. There was no history of recent chest trauma. Because of worsening respiratory distress and persistent hypotension despite oxygenation and fluid loading, she required endotracheal intubation and dopamine administration.
Laboratory findings on hospital admission were as follows: hemoglobin, 5.7 g/dL; fibrinogen, 3.5g/L; and anti-Xa, 1.44 IU/mL; the platelet count and prothrombin time were normal. The serum creatinine level was 280 mol/L. The chest radiograph was notable for a recently enlarged mediastinum and bilateral pleural effusion. A left-sided thoracentesis was performed that drained 800 mL of hemorrhagic fluid. A transesophageal echocardiography found neither pericardial effusion nor aortic dissection. A dynamic CT scan of the thorax (Fig 1) revealed a large anterior hemomediastinum compressing the pulmonary arteries, trachea, and main bronchi, and large bilateral pleural effusions. Evidence of a contrast material leak on the left part of the hematoma suggested active bleeding. Thoracic aortography with selective opacification of the carotid, internal mammary, and subclavicular arteries showed no vascular abnormality. Despite supportive treatment, shock persisted and a sternotomy was performed for surgical control of bleeding. Operative findings revealed a large infiltration of the anterior mediastinum by diffuse hemorrhagic fat under tension. Exploration of the mediastinum revealed no tumor, and both pleural spaces and pericardium appeared normal, except for nonclotting hemorrhagic fluid. The operative diagnosis was a spontaneous mediastinal hemorrhage secondary to bleeding from steroidinduced ML. The hemorrhagic fat was resected to decompress the mediastinum. The patient's clinical status rapidly improved, and weaning from mechanical ventilation was achieved on postoperative day 4. There was no recurrence of bleeding after surgery. Treatment with corticosteroids was continued at lower doses, and enoxaparin, 40 mg/d, was introduced for the prevention of venous thromboembolism.
Discussion
Hemomediastinum is a rare clinical event, usually secondary to nonpenetrating trauma, rupture of the descending aorta, aorta or vertebral artery dissection, or occurring after surgery or angiography. 4 Spontaneous mediastinal hemorrhage occurs in three circumstances: (1) hemomediastinum secondary to abnormal clotting or fibrinolysis associated with hemodialysis, anticoagulant or fibrinolytic therapy, or hemophilia ; (2) hemomediastinum secondary to hemorrhage into mediastinal glands, cysts, or tumors; and (3) "idiopathic" hemomediastinum occurring after a sudden increase in intrathoracic pressure, during coughing, sneezing or vomiting, or sudden sustained hypertension. 5 Most cases of nontraumatic mediastinal hemorrhage are revealed by chest pain or dyspnea, and hemorrhagic shock is rare. 5 Aortic dissection is the main differential diagnosis. Surgery may be required for assessment or treatment of mediastinal compression and/or life-threatening bleeding. However, in hemophilic patients with no severe hemomediastinum, a conservative approach is advocated with correction of the coagulation defect to avoid postoperative complications. 6 ML is recorded in about 15% of patients receiving high doses of corticosteroids. 3 In Cushing's disease, steroidinduced lipomatosis has an acute or subacute axial development, often involving the retro-orbital or epidural spaces. ML is usually asymptomatic and fortuitously suspected by the radiologic finding of an enlarged mediastinum. 3 However, lipomatosis may become compressive and may produce cough, dyspnea, or superior vena caval syndrome. The diagnosis is easily confirmed by fatty density on CT scan or MRI. 7 Steroid-induced ML improves in most patients following decreasing steroid dosage, but surgical decompression of the mediastinum may be necessary in severe forms. 3 In our patient, the recent increase of steroid therapy associated with the development of both exophthalmia and enlarged mediastinum were highly suggestive of steroid-induced lipomatosis, which was confirmed by surgical and pathologic findings. To the best of our knowledge, hemorrhagic complications of ML have never been described. However, fat tissues have dense vascularization, and gastric or colonic lipomatosis has been associated with GI bleeding.
In our patient, the use of LMWH in the context of chronic renal failure likely contributed to mediastinal fat hemorrhage. LMWH should be used very cautiously in patients with renal insufficiency because of an increased risk of hemorrhagic complications, and plasma anti-factor Xa concentrations have to be monitored in such patients. 1, 2 Although hemomediastinum is an uncommon complication of LMWH therapy, this diagnosis should be suspected in a patient presenting with an enlarged mediastinum and no evidence of aortic dissection. Among the various conditions associated with spontaneous hemomediastinum, ML should be considered in patients receiving long-term, high-dose steroids.
Pergolide is an ergot-derived dopamine agonist used in Parkinson's disease and, increasingly, in restless legs syndrome. We report a patient with a 2.5-year history of weight loss, pleuropulmonary fibrosis, and exudative pleural effusion that developed insidiously while taking this medication. The extensive and invasive workup that preceded the diagnosis highlights the difficulty in attributing such a process to a drug reaction. This is the second report of such a reaction to pergolide, which is one of the increasing number of ergot-derived compounds in common clinical use.
( T he ergot-derived alkaloids comprise a large number of compounds sharing a common ring structure and include several medications frequently used for Parkinson's disease (PD) and migraine headaches, among others (Table 1) . A number of these compounds have been described to produce a pleuropulmonary fibrosis syndrome, 1 in addition to retroperitoneal fibrosis. 2 The diagnosis of this drug-associated pleuropulmonary fibrosis syndrome is largely one of exclusion and is often made with some difficulty given the presence of coexisting medical problems. It is confirmed by response to withdrawal of the offending agent. Pergolide, an ergot-derived alkaloid, was introduced as an adjunct therapy for PD 3 and has subsequently been used with some success for restless legs syndrome (RLS). 4 We wish to report a case of pergolide-induced pleuropulmonary fibrosis.
Case Report
A 65-year-old white man was transferred to our institution for evaluation of progressive weight loss (50 lb total), increasing dyspnea, and fatigue noted, retrospectively, to have begun Ͼ 2 years earlier. Workup that included chest and abdominal CT, barium enema, and sigmoidoscopy had been unrevealing. Six months prior to transfer, the patient was incidentally noted to 
